Peeters T L, Bormans V, Vantrappen G
Department of Medical Research, University of Leuven, Belgium.
Regul Pept. 1988 Nov;23(2):171-82. doi: 10.1016/0167-0115(88)90025-0.
Pharmacological studies indicate that in man and in rabbit, but not in dog, motilin has a direct influence upon gastrointestinal smooth muscle. In accordance with this hypothesis we have presented direct biochemical evidence for the presence of motilin receptors on rabbit smooth muscle tissue. We have now extended our studies to human and canine tissue. Tissue homogenates were studied in binding experiments with iodinated porcine [Leu13]motilin and iodinated canine motilin. It was ascertained that the iodination procedure had little effect on the biological activity of the porcine analogue. In the human antrum specific binding of the iodinated porcine analogue was only found in the smooth muscle layer. It was absent in mucosal or serosal preparations. At 30 degrees C and pH 8.0, binding was maximal after 60 min of incubation, and was reversed by the addition of unlabeled porcine motilin. Binding was enhanced in the presence of calcium and magnesium ions. At a concentration of 10 mM MgCl2, binding was 220% of the binding observed in its absence. Displacement studies with synthetic porcine [Leu13]motilin or synthetic natural porcine motilin indicated a dissociation constant (Kd) of 3.6 +/- 1.6 nM and a maximal binding capacity (Bmax) of 77 +/- 9 fmol per mg protein. Canine motilin displaced iodinated porcine motilin with an apparent Kd of 2.2 +/- 0.9 nM. Compared to antral binding, receptor density decreased aborally and orally, and was absent in jejunum and ileum. In dog specific binding could not be demonstrated in antral and duodenal tissue, neither with labeled porcine nor with labeled canine motilin. However, labeled canine motilin was equipotent to labeled porcine motilin in binding studies with human tissue: the dissociation constant was 0.9 +/- 0.6 nM. The present studies therefore demonstrate the existence of a specific motilin receptor in the antroduodenal region of the human gut. Apparently, such receptors are not present in the canine gut. Our data support the hypothesis that in the human gastrointestinal tract, the gastroduodenal area is motilin's target region.
药理学研究表明,在人和兔体内,胃动素对胃肠道平滑肌有直接影响,但在犬体内则不然。根据这一假说,我们提供了兔平滑肌组织上存在胃动素受体的直接生化证据。现在我们已将研究扩展到人和犬的组织。在用碘化猪[亮氨酸13]胃动素和碘化犬胃动素进行的结合实验中研究了组织匀浆。已确定碘化过程对猪类似物的生物活性影响很小。在人胃窦中,碘化猪类似物的特异性结合仅在平滑肌层中发现。在黏膜或浆膜制剂中未发现。在30℃和pH 8.0条件下,孵育60分钟后结合达到最大值,并可通过加入未标记的猪胃动素使其逆转。在钙和镁离子存在下结合增强。在10 mM MgCl2浓度下,结合是在其不存在时观察到的结合的220%。用合成猪[亮氨酸13]胃动素或合成天然猪胃动素进行的置换研究表明,解离常数(Kd)为3.6±1.6 nM,最大结合容量(Bmax)为每毫克蛋白质77±9 fmol。犬胃动素以2.2±0.9 nM的表观Kd置换碘化猪胃动素。与胃窦结合相比,受体密度在口侧和肛侧降低,在空肠和回肠中不存在。在犬体内,无论是用标记的猪胃动素还是标记的犬胃动素,在胃窦和十二指肠组织中均未证明有特异性结合。然而,在用人组织进行的结合研究中,标记的犬胃动素与标记的猪胃动素效力相当:解离常数为0.9±0.6 nM。因此,目前的研究证明了人肠道胃十二指肠区域存在特异性胃动素受体。显然,这种受体在犬肠道中不存在。我们的数据支持这样一种假说,即在人类胃肠道中,胃十二指肠区域是胃动素的靶区域。